Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Evolution of Quality of Life in Renal Transplant Recipients and Patients With Multiple Sclerosis: A Follow-up Study.
Steps Per Day Among Persons With Multiple Sclerosis: Variation by Demographic, Clinical, and Device Characteristics.
Neurological diseases in pregnancy.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.
Learning a cost function for microscope image segmentation.
[Current therapy of multiple sclerosis].
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Multiple sclerosis: Diurnal variations in serum markers of inflammation-an avoidable source of bias in MS studies?
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
A case of neuromyelitis optica spectrum disorder presenting with severe orthostatic hypotension.
Orthognathic Surgery in a Patient with Multiple Sclerosis.
Class II HLA interactions modulate genetic risk for multiple sclerosis.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Exercise therapy and multiple sclerosis: a systematic review.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »